| Catalog No. | 
			TD-VK623026 | 
		
		
			| Species reactivity | 
			Zaire ebolavirus (ZEBOV) | 
		
		
			| Applications | 
			Research Grade Biosimilar | 
		
		
			| Host species | 
			Human | 
		
		
			| Isotype | 
			IgG1, kappa | 
		
		
			| Expression system | 
			Mammalian Cells | 
		
		
			| Clonality | 
			Monoclonal | 
		
		
			| Target | 
			Envelope glycoprotein, GP1,2, GP, Shed GP, GP1,2-delta, GP1, GP2, GP | 
		
		
			| Endotoxin level | 
			Please contact the lab for this information. | 
		
		
			| Purity | 
			>95% purity as determined by SDS-PAGE. | 
		
		
			| Purification | 
			Protein A/G, purified from cell culture supernatant. | 
		
		
			| Accession | 
			Q05320 | 
		
		
			| Form | 
			Liquid | 
		
		
			| Storage buffer | 
			0.01M PBS,pH7.4. | 
		
		
			| Stability and Storage | 
			Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. | 
		
		
			| Alternate Names | 
			REGN-3470-3471-3479,REGN-3470/REGN-3471/REGN-3479,REGN-EB3,REGNEB3,Inmazeb(atoltivimab,maftivimab,odesivimab-ebgn),CAS:2135632-30-1 | 
		
		
			| Background | 
			Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection. | 
		
		
			| Note | 
			For research use only. Not for use in clinical or therapeutic applications. |